相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Left ventricular remodeling and dysfunction in primary aldosteronism
Cheng-Hsuan Tsai et al.
JOURNAL OF HUMAN HYPERTENSION (2021)
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
Wei-Chieh Huang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Primary aldosteronism is a public health issue: challenges and opportunities
Renata Libianto et al.
JOURNAL OF HUMAN HYPERTENSION (2020)
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success
Kang-Yung Peng et al.
HYPERTENSION (2020)
Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion
Judith Gerards et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI tria
Heerajnarain Bulluck et al.
AMERICAN HEART JOURNAL (2019)
Mortality From Ischemic Heart Disease Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration
Alexandra N. Nowbar et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Endothelial Dysfunction in Primary Aldosteronism
Zheng-Wei Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Global Burden of Cardiovascular Diseases and Risk Factors 2020 and Beyond
George A. Mensah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Left ventricular dysfunction causing ischemia in patients with patent coronary arteries
Thach Nguyen et al.
PERFUSION-UK (2018)
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism A Multicenter Study in Japan
Youichi Ohno et al.
HYPERTENSION (2018)
Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism
Gregory L. Hundemer et al.
HYPERTENSION (2018)
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
Gregory L. Hundemer et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis
Silvia Monticone et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy
Christian Adolf et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism
Youichi Ohno et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism
Sophocles Chrissobolis
CURRENT HYPERTENSION REVIEWS (2017)
Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries
Katherine T. Mills et al.
CIRCULATION (2016)
Early Aldosterone Blockade in Acute Myocardial Infarction The ALBATROSS Randomized Clinical Trial
Farzin Beygui et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Treatment of Hypertension in Patients With Coronary Artery Disease A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension
Clive Rosendorff et al.
CIRCULATION (2015)
Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients
Carrie C. Lubitz et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase
Riccardo Urbanet et al.
HYPERTENSION (2015)
Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients
Carrie C. Lubitz et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
Rajesh Garg et al.
DIABETES (2015)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
CIRCULATION (2014)
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study
Gilles Montalescot et al.
EUROPEAN HEART JOURNAL (2014)
Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up
Antonino Mignano et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2014)
Effects of aldosterone on insulin sensitivity and secretion
James M. Luther
STEROIDS (2014)
Changes in the clinical manifestations of primary aldosteronism
Sun Hwa Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara et al.
CIRCULATION (2013)
Inhibition of the Renin-Angiotensin System Reduces the Rise in Serum Aldosterone in Acute Coronary Syndrome Patients with Preserved Left Ventricular Function: Observations from the AVANT GARDE-TIMI 43 Trial
Jacob A. Udell et al.
CLINICAL CHEMISTRY (2013)
Aldosterone and the Risk of Hypertension
Vanessa Xanthakis et al.
CURRENT HYPERTENSION REPORTS (2013)
Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study
Sebastien Savard et al.
HYPERTENSION (2013)
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Paolo Mulatero et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Hypercortisolism Is Associated With Increased Coronary Arterial Atherosclerosis: Analysis of Noninvasive Coronary Angiography Using Multidetector Computerized Tomography
Nicola M. Neary et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Observational Study Mortality in Treated Primary Aldosteronism The German Conn's Registry
Martin Reincke et al.
HYPERTENSION (2012)
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone
Natalia Lopez-Andres et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
11 beta-Hydroxysteroid Dehydrogenase Type 2 Deficiency Accelerates Atherogenesis and Causes Proinflammatory Changes in the Endothelium in Apoe(-/-) Mice
Graeme A. Deuchar et al.
ENDOCRINOLOGY (2011)
Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn's Registry
E. Born-Frontsberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Cardiovascular outcomes in patients with primary aldosteronism after treatment
Cristiana Catena et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction
Farzin Beygui et al.
CIRCULATION (2006)
Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology
JN Cohn et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Prevalence and characteristics of the metabolic syndrome in primary aldosteronism
F Fallo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
P Milliez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction
E Perrier et al.
CIRCULATION (2004)
Serum aldosterone and the incidence of hypertension in nonhypertensive persons
RS Vasan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Aldosterone directly stimulates cardiac myocyte hypertrophy
MP Okoshi et al.
JOURNAL OF CARDIAC FAILURE (2004)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Kidney disease as a risk factor for development of cardiovascular disease - A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention
MJ Sarnak et al.
HYPERTENSION (2003)
分享论文
